About this trial

Gestational diabetes mellitus (GDM) is one of the most common disorders which occured during pregnancy. GDM is not only associated with short-term maternal and fetal adverse outcomes, but also related to a wide range of long-term consequences for both mother and child. The GDM and Its Consequences for mothers and offsprings (GDMCMO) aims to establish a cohort to follow both maternal and offsprings'short-term and long-term outcomes, including fetal malformations including congenital heart diseases, birth weight, preterm birth, caesarean section delivery, body growth and neurodevelopment after birth, obesity, type 2 diabetes and impaired insulin sensitivity and secretion, lung health and allergic diseases later in life for offspring, as well as future type 2 diabetes and cardiovascular risk factors for mother after delivery. Biological samples including blood and tissue samples of mothers and children are also collected during pregnancy and after delivery.

Eligibility criteria

Qualifiers

Pregnant women diagnosed with gestational diabetes mellitus

Pregnant women intended to eventually deliver in Guangzhou Women and Children's Medical Center

Permanent residents or families intended to remain in Guangzhou with their child for no less than 3 years

Disqualifiers

Women with pre-gestational diabetes mellitus

Women with chronic hypertension or kidney disease

Trial design

Treatments tested in this trial

Treatment groups

No treatment groups listed

Locations

1
Guangzhou Women and Children's Medical Center510623, GuangzhouGuangdong, China

Sponsors and collaborators

Guangzhou Women and Children's Medical Center

Lead sponsor